Display Settings:

Format

Send to:

Choose Destination
    BMC Biochem. 2005 Sep 9;6:16.

    Analysis of Escherichia coli nicotinate mononucleotide adenylyltransferase mutants in vivo and in vitro.

    Source

    Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden. martin.stancek@invitro.se

    Abstract

    BACKGROUND:

    Adenylation of nicotinate mononucleotide to nicotinate adenine dinucleotide is the penultimate step in NAD+ synthesis. In Escherichia coli, the enzyme nicotinate mononucleotide adenylyltransferase is encoded by the nadD gene. We have earlier made an initial characterization in vivo of two mutant enzymes, NadD72 and NadD74. Strains with either mutation have decreased intracellular levels of NAD+, especially for one of the alleles, nadD72.

    RESULTS:

    In this study these two mutant proteins have been further characterized together with ten new mutant variants. Of the, in total, twelve mutations four are in a conserved motif in the C-terminus and eight are in the active site. We have tested the activity of the enzymes in vitro and their effect on the growth phenotype in vivo. There is a very good correlation between the two data sets.

    CONCLUSION:

    The mutations in the C-terminus did not reveal any function for the conserved motif. On the other hand, our data has lead us to assign amino acid residues His-19, Arg-46 and Asp-109 to the active site. We have also shown that the nadD gene is essential for growth in E. coli.

    PMID:
    16153292
    [PubMed - indexed for MEDLINE]
    PMCID: PMC1249556
    Free PMC Article

    Images from this publication.See all images (3) Free text

    Figure 2
    Figure 3
    Figure 1

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk